लोड हो रहा है...
Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients
BACKGROUND: Secondary hyperparathyroidism (SHPT) is a serious and common complication in patients receiving peritoneal dialysis (PD). Cinacalcet is currently the recommended therapy for SHPT; however, gastrointestinal (GI)-related symptoms can result in low adherence and high discontinuation rates....
में बचाया:
| में प्रकाशित: | Clin Exp Nephrol |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer Singapore
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586709/ https://ncbi.nlm.nih.gov/pubmed/30955188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-019-01692-y |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|